The association between the measurement of adherence to anti-diabetes medicine and the HbA1c

International Journal of Clinical Pharmacy

Volumn 36, Issue 3, 2014, Pages 488-497

  Doggrell, Sheila A ^a   Warot, Servane ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Adherence; Adherence measurement; Anti diabetes medicines; Diabetes Mellitus; HbA1c; Medicines possession ratio (MPR); MMAS; Morisky adherence scale

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

GLYCEMIC CONTROL; HUMAN; MEDICINES POSSESSION RATIO; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; REVIEW; ANALYSIS; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; MEDICATION COMPLIANCE; STATISTICS AND NUMERICAL DATA;

BLOOD GLUCOSE; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MEDICATION ADHERENCE;

EID: 84901429586     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-014-9929-6     Document Type: Review

References (39)

1. Stratton IM, Adler AI, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-12. (Pubitemid 30609442)
2. Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY, Astor BC, Sharrett AR, Brancati FL, Coresh J. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes. 2011;60(1):298-305.
3. Rogvi S, Tapager I, Almdal P, Schiøtz ML, Willaing I. Patient factors and glycaemic control - associations and explanatory power. Diabet Med. 2012;29(10):e382-9.
4. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes audit and research in Tayside Scotland, medicines monitoring unit. Lancet. 1997;350(9090):1505-10.
5. Bakrishnan R, RajagopalanR,Camacho FT,Huston SA,Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older populationwith type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25(11):2958-71. (Pubitemid 37510603)
6. Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27(9):2149-53. (Pubitemid 39167177)
7. Ho PM, Rumsfield JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-41. (Pubitemid 44455165)
8. Hepke KL, Martus MT, Share DA. Costs and utilization associated with pharmaceutical adherence in a diabetic population. Am J Manag Care. 2004;10(2 Pt 2):144-51. (Pubitemid 38332389)
9. Kindmalm L, Melander A, Nilsson JL. Refill adherence of antihyperglycaemic drugs related to glucose control (HbA1c) in patients with type 2 diabetes. Acta Diabetol. 2007;44(4):209-13. (Pubitemid 350132265)
10. Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ. 2008;34(4):692-7.
11. Bains SS, Egede LE. Associations between health literacy, diabetes knowledge, self-care behaviors, and glycemic control in a low income population with type 2 diabetes. Diabetes Technol Ther. 2011;13(3):335-41.
12. Cohen HW, Shmukler C, Ullman R, Rivera CM, Walker EA. Measurements of medication adherence in diabetic patients with poorly controlled HbA1c. Diabetic Med. 2010;27:210-6.
13. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74. (Pubitemid 16125389)
14. Coons SJ, Sheahan SL, Martin SS, Hendricks J, Robbins CA, Johnson JA. Predictors of medication noncompliance in a sample of older adults. Clin Ther. 1994;16:110-7. (Pubitemid 24186956)
15. Van De Steeg N, Sielk M, Pentzek M, Bakx C, Altiner A. Drug-adherence questionnaires not valid for patients taking blood-pressure-lowering drugs in a primary health care setting. J Eval Clin Pract. 2009;15:468-72.
16. Shalansky SJ, Levy A, Ignaszewski AP. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacotherap. 2004;38:1363-8. (Pubitemid 39100185)
17. Koschack J, Marx G, Schnakenberg J, Kochen MM, Himmel W. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol. 2010;63:299-306.
18. Andrade SE, Kahler KH, Frech F, Chang KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565-74. (Pubitemid 44336271)
19. Kadmon PM, Gruppuso PA. Glycemic control with metformin or insulin therapy in adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2004;17(9):1185-93. (Pubitemid 39276557)
20. Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, El-Kebbi IM, Gallina DL, Barnes C, Phillips LS. Patient adherence improves glycemic control. Diabetes Educ. 2005;31(2):240-50. (Pubitemid 40529013)
21. Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med. 2007;167(17):1853-60. (Pubitemid 47481480)
22. Mashitani T, Hayashino Y, Okamura S, Kitatani M, Furuya M, Furuya M, Matsunaga K, Kuwata H, Tsuji S, Isi H. Patient-reported adherence to insulin regiment is associated with glycemic control among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 3). Diabetes Res Clin Pract. 2013;100(2):189-94.
23. 1c in type 2 diabetes. Ann Pharmacother. 2004;38(9):1357-62.
24. Hill-Briggs F, Gary TL, Bone LR, Hill MN, Levine DM, Brancati FL. Medication adherence and diabetes control in urban African Americanswith type 2 diabetes.Health Psychol. 2005;24(4):349-57. (Pubitemid 41099135)
25. Al-Qazaz H, Sulaiman SA, Hassali MA, Shafie AA, Sundram S, Al-Nuri R, Saleem F. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm. 2011;33(6):1028-35.
26. Wang Y, Lee J, Toh MPSH, Tang WE, Ko Y. Validity and reliability of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Singapore. Diabet Med. 2012;29:e338-44.
27. Aikens JE, Piette JD. Longitudinal association between medication adherence and glycaemic control in type 2 diabetes. Diabet Med. 2013;30(3):338-44.
28. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25(6):1015-21. (Pubitemid 41110487)
29. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medicationsmeasured by claims data in patients with diabetes. Diabetes Care. 2004;27(12):2800-5. (Pubitemid 39565040)
30. Lawrence DB, Ragucci KR, Long LB, Parris BS, Helfer LA. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program. J Manag Care Pharm. 2006;12(6):466-71. (Pubitemid 47400587)
31. Rozenfeld Y, Hunt JS, Plauschinat C, Wong KS. Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care. 2008;14(2):71-5. (Pubitemid 351312089)
32. Adams AS, Trinacty CM, Zhang F, Kleinman K, Grant RW, Meigs JB, Soumerai SB, Ross-Degnan D. Medication adherence and racial differences in A1C control. Diabetes Care. 2008;31(5):916-21.
33. Horswell RL, Wascom CK, Cerise FP, Besse JA, Johnson JK. Diabetes mellitus medication assistance program: relationship of effectiveness to adherence. J Health Care Poor Underserved. 2008;19(3):677-86.
34. Kim N, Agostini JV, Justice AC. Refill adherence to oral hypoglycemic agents and glycemic control in veterans. Ann Pharmacother. 2010;44(5):800-8.
35. Zhu VJ, Tu W, Marrero DG, Rosenman MR, Overhage JM. Race and medication adherence and glycemic control: findings from an operational health information exchange.In AMIA Annual Symposium Proceedings 2011;1649-57.
36. Donnelly LA, Morris AD, Evans JM. DARTS/MEMO collaboration. Adherence to insulin and its association with glycemic control in patients with type 2 diabetes. QJM. 2007;100(6):345-50. (Pubitemid 47073810)
37. Cramer JA, Pugh MJ. The influence of insulin use on glycemic control: how well do adults follow prescriptions for insulin? Diabetes Care. 2005;28(1):78-83. (Pubitemid 40095786)
38. Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004;42(2):102-9.
39. Ngo-Metzger Q, Sorkin DH, Billimek J, Greenfield S, Kaplan SH. The effects of financial pressures on adherence and glucose control among racial/ethnically diverse patients with diabetes. J Gen Intern Med. 2012;27(4):432-7.